The University of Witwatersrand, Johannesburg, which conducted the
trial, said in a statement that the vaccine "provides minimal
protection against mild-moderate Covid-19 infection" from the variant.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-vaccine-less-effective-against-s-african-strain-study/articleshow/80737283.cms
No comments:
Post a Comment